Sign in
Taking peopleNo phase

Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates

Key facts

Who runs it
University of California, Berkeley
Where
Berkeley, United StatesSee the siteAlso in 1 other country, 1 site
Trial code
Status
Recruiting
People taking part
45,450 people, planned
Started
21 Jan 2025
Expected to end
Jul 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • chlorination for water disinfection and surface disinfection
  • infection prevention and control messaging
Record updated
13 October 2026

Who can take part

Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 10 criteriaShow less

Other criteria

  • Facility Inclusion Criteria:
  • Public health care facility
  • 25 live births or more per month
  • Infrastructure compatible with inline chlorination device; Participant Inclusion Criteria:
  • Pregnant adults/mature minors arriving at enrolled facilities to give birth and their neonates; Facility Exclusion Criteria:
  • Existing facility-level chlorination; Participant Exclusion Criteria:
  • Miscarriage (<28 weeks gestation)
  • Stillbirth (for neonatal analysis only)
  • Unable to give informed consent/do not consent
  • Reside >2 hours away from facility for enrollment into swab sampling cohort

Where in United States

Also in 1 other country, 1 site

  • University of California, BerkeleyBerkeley, United StatesContact: Amy J Pickering, PhDNo longer taking part

About the trial

What the trial wants to find out

The CLEAN (ChLorine to reduce Enteric and Antibiotic resistant infections in Neonates) cluster randomized controlled trial in western Kenya will evaluate the impact of a multi-component chlorination intervention in health care facilities on maternal and neonatal health. Intervention facilities will receive a passive chlorination technology for water supply treatment and a reliable supply of sodium hypochlorite disinfectant. Both intervention and treatment facilities will receive infection prevention and control messaging. The goal of the study is to evaluate the impact of the intervention on bacterial contamination of water supply, on staff hands, and on high-touch surfaces in maternity wards, and the following outcomes among facility-born neonates and their mothers: (1) gut carriage of bacterial pathogens associated with sepsis one week post-birth, (2) gut carriage of antibiotic resistant bacteria one week post-birth, and (3) symptoms of possible serious bacterial infection one week following birth.

The 2 groups in the trial

  • ControlExisting treatment, for comparison

    Control group. At the conclusion of the trial, facilities will receive a chlorine doser.

    Treatment: infection prevention and control messaging

  • Multi-component chlorine interventionTreatment being tested

    Health care facilities will receive one or more inline chlorine dosers that will automatically chlorinate all water accessed by the maternity wards. Intervention facilities will also be randomized to either receive an electrochlorinator for on-site production of liquid chlorine solution or to receive bulk chlorine deliveries. Chlorine will be use to refill the chlorine dosers and for surface disinfection. Facilities will also receive hardware to facilitate surface disinfection.

    Treatment: chlorination for water disinfection and surface disinfection and infection prevention and control messaging

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Multi-component Chlorination Intervention to Reduce Neonatal Infections in Rural Health Facilities
Publications
Record updated
13 October 2026